Login / Signup

ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD).

Eloyse Cristina BotacinSebastião Mauro Bezerra DuarteJose Tadeu StefanoMary Ellen Dias BarbosaMario Guimarães PessoaClaudia Pinto Marques Souza de Oliveira
Published in: Arquivos de gastroenterologia (2024)
The findings point to the presence of anxiety and depression in more than one third of MASLD patients, most with severe symptoms. The group is concentrated in the elderly, with many comorbidities, including MetS. There was a positive correlation between anxiety, depression and being female; also, being significant between MetS and depression.
Keyphrases
  • sleep quality
  • end stage renal disease
  • depressive symptoms
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • oxidative stress
  • patient reported outcomes
  • drug induced
  • patient reported